Gene therapy of muscular dystrophy

被引：84
|
作者：
Chamberlain, JS [1 ]
机构：
[1] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA
来源：
HUMAN MOLECULAR GENETICS | 2002年 / 11卷 / 20期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1093/hmg/11.20.2355
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Development of gene therapy for the muscular dystrophies represents a daunting challenge requiring significant advances in our knowledge of the defective genes, muscle promoters, viral vectors, immune system surveillance and methods for systemic delivery of vectors. However, tremendous progress has been made in developing improved viral vectors and avoiding immune reactions against gene transfer. This review summarizes recent progress and highlights problems that must be solved before an effective treatment is available.
引用
收藏
页码：2355 / 2362
页数：8
相关论文
共 50 条
  • [1] Surrogate gene therapy for muscular dystrophy
    Davies, Kay E.
    Chamberlain, Jeffrey S.
    NATURE MEDICINE, 2019, 25 (10) : 1473 - 1474
  • [2] Gene therapy for Duchenne muscular dystrophy
    Suzuki, Naoki
    Miyagoe-Suzuki, Yuko
    Takeda, Shin'ichi
    FUTURE NEUROLOGY, 2007, 2 (01) : 87 - 96
  • [3] Developments in gene therapy for muscular dystrophy
    Hartigan-O'Connor, D
    Chamberlain, JS
    MICROSCOPY RESEARCH AND TECHNIQUE, 2000, 48 (3-4) : 223 - 238
  • [4] Duchenne Muscular Dystrophy Gene Therapy
    Saad, Fawzy A.
    Saad, Jasen F.
    Siciliano, Gabriele
    Merlini, Luciano
    Angelini, Corrado
    CURRENT GENE THERAPY, 2024, 24 (01) : 17 - 28
  • [5] Gene therapy in canine muscular dystrophy
    Takeda, Shin'ichi
    NEUROMUSCULAR DISORDERS, 2006, 16 : S52 - S52
  • [6] Gene therapy of Duchenne muscular dystrophy
    Dickson, G
    CHEMISTRY & INDUSTRY, 1996, (08) : 294 - 297
  • [7] Gene therapy for Duchenne muscular dystrophy
    Verhaart, Ingrid E. C.
    Aartsma-Rus, Annemieke
    CURRENT OPINION IN NEUROLOGY, 2012, 25 (05) : 588 - 596
  • [8] Gene therapy for Duchenne muscular dystrophy
    Ramos, Julian
    Chamberlain, Jeffrey S.
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (11): : 1255 - 1266
  • [9] Gene Therapy for Duchenne Muscular Dystrophy
    Elangkovan, Nertiyan
    Dickson, George
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 : S303 - S316
  • [10] Gene therapy for oculopharyngeal muscular dystrophy
    Malerba, A.
    Klein, P.
    Bachtarzi, H.
    Jarmin, S.
    Cordova, G.
    Ferry, A.
    Strings, V.
    Espinoza, M. Polay
    Mamchaoui, K.
    Blumen, S.
    St Guily, J. Lacau
    Mouly, V.
    Graham, M.
    Butler-Browne, G.
    Suhy, D.
    Trollet, C.
    Dickson, G.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S245 - S246
12345